Please log in to get access to this content
The official presentation of the international guideline on the prevention and management of the manifestations of CVD in patients with diabetes. The current guideline provides recommendations for how to reduce CV risk in patients with diabetes, and how to treat those with clinical manifestations of cardio-renal disease such as atherosclerotic CV disease, heart failure, atrial fibrillation, and chronic kidney disease.
Speakers
- Nikolaus Marx
RWTH University Hospital Aachen - Aachen, Germany - Massimo Federici
University of Rome Tor Vergata - Rome, Italy
Disclaimer
© 2023 European Society of Cardiology. All rights reserved. ESC® and the ESC logo are registered trademarks of the European Society of Cardiology. Used with permission.
This content is provided for informational purposes and personal use only, and is not intended to provide medical advice, diagnosis, or treatment or for commercial use. The ideas and opinions expressed herein do not necessarily reflect those of the European Society of Cardiology (ESC®) or SpringerMedicine.com. The mention of any product, service or therapy in this collection of materials should not be construed as an endorsement of the products mentioned.